文献速递烧伤创面修复

烧伤后毛霉病:一项系统综述

Mucormycosis following burn injuries: A systematic review.
PubMed 文献 · Burns · 2022-05-13

该系统综述纳入46篇文献共114例烧伤合并毛霉病患者,比较存活与死亡者的临床特征。存活者平均烧伤总面积46%(SD 19.8),死亡者为65%(SD 16.4),差异有统计学意义(p < .001)。播散性感染死亡率为80%,局限性疾病为36%(p < .001);糖尿病与死亡率无显著关联。

要点

  • 烧伤合并毛霉病中,播散性感染死亡率80%,局限性疾病36%(p < .001)。
  • 死亡者平均烧伤总面积65%(SD 16.4),存活者46%(SD 19.8),差异有统计学意义(p < .001)。
  • 糖尿病、平均年龄、诊断延迟、抗真菌治疗时间及治疗类型与死亡率均无显著差异(p > .05)。

核心结论

  • 播散性感染和更高的烧伤总面积均增加烧伤合并毛霉病患者的死亡风险,而糖尿病不增加死亡风险。
  • 初始损伤严重程度和感染部位应纳入患者预后评估。

研究设计与样本

  • 系统综述,检索Pubmed和Google Scholar,纳入临床试验、观察性研究、病例报告和病例复习,最终纳入46篇文献共114例成人及儿童烧伤合并毛霉病患者。
  • 采用牛津证据等级评价研究质量,按死亡率对个体患者数据进行分层分析。

主要发现

  • 存活者平均烧伤总面积为46%(SD 19.8),死亡者为65%(SD 16.4),差异有统计学意义(p < .001)。
  • 播散性毛霉病患者死亡率为80%,局限性疾病患者为36%(p < .001)。
  • 存活者与死亡者之间平均年龄、糖尿病、平均诊断延迟、抗真菌治疗时间及治疗类型均无统计学显著差异(p > .05)。

局限性

  • 缺乏前瞻性对照试验,本综述主要由病例报告组成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Mucormycosis is an opportunistic fungal infection with a high mortality rate. Though typically associated with diabetes and other conditions that affect innate immune function, infections can also be precipitated by conditions such as trauma and burns. Burn patients are particularly susceptible to fungal infections due to the immune dysfunction that often accompany their wounds. Indeed case series have described mucormycosis to occur in patients with burn injuries, however the factors contributing to mortality have not been well described. Thus, the purpose of our review was to identify factors contributing to morbidity and mortality in burn patients with Mucormycosis. METHODS: A systematic review of the literature of mucormycosis infection in burn injury patients was performed on Pubmed and Google Scholar using the keywords: Mucor, Mucorales, Mucormycosis, Mucormycotina, Zygomycosis and burn or thermal injury. Clinical trials, observational studies, case reports, and case reviews were included if they provided information regarding mortality in adult and pediatric burn patients diagnosed with mucormycosis, review articles, non-English articles, and articles without patient information were excluded. No time limit was placed on our review. Individual patient data was stratified based on mortality. Statistical analysis was performed to investigate the relationship between patient risk factors and mortality, and the Oxford Level of Evidence was used to evaluate study quality. RESULTS: 46 articles were included in our final review, encompassing 114 patients. On average, survivors had a total body surface area (TBSA)% of 46 (SD 19.8) while non-survivors had a TBSA of 65% (SD 16.4), and this difference was significant (p < .001). Patients with disseminated mucormycosis experienced an 80% mortality rate compared to 36% mortality rate in patients with localized disease (p < .001). We found no statistically significant difference in mean age (p > .05), diabetes (p > .05), mean delay in diagnosis (p > .05), time to antifungal therapy (p > .05), or type of therapy used (p > .05) between survivors and non-survivors. Our review was limited by the lack of prospective, controlled trials; thus, our review primarily consists of case reports. CONCLUSION: Disseminated infections and higher TBSA both increased the risk of mortality in burn patients with mucormycosis, while diabetes did not increase mortality risk. The severity of the initial injury and infection locations must be taken into consideration to inform patient prognosis.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Dang J, Goel P, Choi KJ, et al. Mucormycosis following burn injuries: A systematic review. Burns. 2022. PMID: 35842270. doi:10.1016/j.burns.2022.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。